OAM
BIND

Oxford Asset Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Oxford Asset Management’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,842
Closed -$45K – 1040
2015
Q4 		$45K Buy
+20,842
New +$84.2K ﹤0.01% 859

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Oxford Asset Management's BIND Position: Q1 2016 in Review

Oxford Asset Management sold out of BIND THERAPEUTICS INC (BIND) in Q1 2016, closing a stake of 20,842 shares — an estimated $45K sold.

Oxford Asset Management first reported a position in BIND in Q4 2015 and held it in 1 quarter. The position peaked at $45K in Q4 2015. 34 funds tracked by Wall St. Rank hold BIND as of Q1 2016.

  • Oxford Asset Management reported no remaining BIND THERAPEUTICS INC position as of Q1 2016 after selling out during the quarter.
  • Oxford Asset Management sold 20,842 BIND THERAPEUTICS INC shares in Q1 2016, an estimated $45K.
  • Oxford Asset Management first reported a position in BIND THERAPEUTICS INC in Q4 2015 and held it in 1 quarter.
  • Oxford Asset Management's BIND THERAPEUTICS INC position peaked at $45K in Q4 2015.
  • 34 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q1 2016.

Based on Oxford Asset Management's 13F filing for Q1 2016, filed 9 May 2016.